LiZRichardsSSurksHK, et al. Clinical pharmacology of alemtuzumab, an anti-CD52 immunomodulator, in multiple sclerosis. Clin Exp Immunol2018; 194(3): 295–314.
6.
UlbrichtDDiederichNJHermanns-LeT, et al. Cervical artery dissection: An atypical presentation with Ehlers-Danlos-like collagen pathology. Neurology2004; 63(9): 1708–1710.
7.
ArnoldMDeMarchisGMStapfC, et al. Triple and quadruple spontaneous cervical artery dissection: Presenting characteristics and long-term outcome. J Neurol Neurosurg Psychiatry2009; 80(2): 171–174.
8.
BejotYDaubailBDebetteS, et al. Incidence and outcome of cerebrovascular events related to cervical artery dissection: The Dijon Stroke Registry. Int J Stroke2014; 9(7): 879–882.
